A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin

Hodgkin's lymphoma patients treated with an anti-CD25 Ricin toxin A-chain (RTA)-based Immunotoxin (RFT5.dgA) develop an immune response against the toxic moiety of the immunoconjugate. The anti-RTA antibody response of 15 patients showing different clinical features and receiving different tota...

Full description

Saved in:
Bibliographic Details
Main Authors: CASTELLETTI, D, FRACASSO, G, RIGHETTI, S, TRIDENTE, G, SCHNELL, R, ENGERT, A, COLOMBATTI, M
Format: Article
Language:English
Published: Blackwell Science Inc 2004
Subjects:
Clinical Studies
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1809030/
https://ncbi.nlm.nih.gov/pubmed/15086403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2004.02442.x
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://ncbi.nlm.nih.gov/pmc/articles/PMC1809030/
https://ncbi.nlm.nih.gov/pubmed/15086403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2004.02442.x

Similar Items